Evidence map›Paper›PMID 39214074›Full record

ArticleThe ISME journal2024

Interplay between particle size and microbial ecology in the gut microbiome.

Jeffrey Letourneau, Verónica M Carrion, Jun Zeng, Sharon Jiang, Olivia W Osborne, Zachary C Holmes, Aiden Fox, Piper Epstein, Chin Yee Tan, Michelle Kirtley and 2 more

Abstract read
In one paragraph

Article in The ISME journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jeffrey LetourneauDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Verónica M CarrionDuke Office of Clinical Research, Duke University School of Medicine, Durham, NC 27710, United States.
Jun ZengDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Sharon JiangDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Olivia W OsborneDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Zachary C HolmesDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Aiden FoxDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Piper EpsteinDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Chin Yee TanDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Michelle KirtleyDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Neeraj K SuranaDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.
Lawrence A DavidDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, United States.

Funding

Personalizing prebiotic therapies that target human gut microbiotaR01DK116187 · NIDDK · DUKE UNIVERSITY · PI Lawrence Anthony David · 2018 to 2026
$3.7M
NIDDK NIH HHS R01 DK116187NIH HHS 1R01DK116187North Carolina Biotechnology Center 2016-IDG-1013Office of Naval Research N00014-18-1-2616
6 · The paper itself

Abstract

Physical particles can serve as critical abiotic factors that structure the ecology of microbial communities. For non-human vertebrate gut microbiomes, fecal particle size (FPS) has been known to be shaped by chewing efficiency and diet. However, little is known about what drives FPS in the human gut. Here, we analyzed FPS by laser diffraction across a total of 76 individuals and found FPS to be strongly individualized. Contrary to our initial hypothesis, a behavioral intervention with 41 volunteers designed to increase chewing efficiency did not impact FPS. Dietary patterns could also not be associated with FPS. Instead, we found evidence that human and mouse gut microbiomes shaped FPS. Fecal samples from germ-free and antibiotic-treated mice exhibited increased FPS relative to colonized mice. In humans, markers of longer transit time were correlated with smaller FPS. Gut microbiota diversity and composition were also associated with FPS. Finally, ex vivo culture experiments using human fecal microbiota from distinct donors showed that differences in microbiota community composition can drive variation in particle size. Together, our results support an ecological model in which the human gut microbiome plays a key role in reducing the size of food particles during digestion. This finding has important implications for our understanding of energy extraction and subsequent uptake in gastrointestinal tract. FPS may therefore be viewed as an informative functional readout, providing new insights into the metabolic state of the gut microbiome.

Indexed as

FecesGastrointestinal MicrobiomeParticle SizeAdultAnimalsBacteriaDietFemaleHumansMaleMasticationMiceMice, Inbred C57BLMiddle AgedYoung Adultdigestiongut microbiomemicrobial ecologymicrobial metabolismparticle size

Identifiers

PMID39214074
PMCPMC11406467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.